These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6705181)

  • 1. Toxic oil syndrome, clinical and immunological characteristics: a review.
    Blanca M; Boulton P; Brostoff J
    Clin Allergy; 1984 Mar; 14(2):165-8. PubMed ID: 6705181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic oil syndrome--an example of an exogenously-induced autoimmune disease].
    Bell S; Brand K; Meurer M
    Hautarzt; 1992 Jun; 43(6):339-43. PubMed ID: 1628965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary function tests at different stages of toxic oil syndrome].
    Martin Escribano P; Fernandez Sanchez Alarcos JM; Dominguez-Lozano MJ; Diaz de Atauri J; Barbosa-Ayucar C; Cantalapiedra JA; Lopez Encuentra A
    Bull Eur Physiopathol Respir; 1984; 20(4):307-12. PubMed ID: 6478085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome.
    Marquet A; Larraga V; Diez JL; Amela C; Rodrigo J; Muñoz E; Pestaña A
    Experientia; 1984 Sep; 40(9):977-80. PubMed ID: 6205897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid anilides and the toxic oil syndrome.
    Lancet; 1982 Jan; 1(8263):98-9. PubMed ID: 6119506
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
    Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
    Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin and autoantibody responses in MRL/lpr mice treated with 'toxic oils'.
    Koller LD; Stang BV; Hall JA; Posada de la Paz M; Ruiz Mendez MV
    Toxicology; 2002 Sep; 178(2):119-33. PubMed ID: 12160619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunnity in patients with Spanish toxic oil syndrome.
    Gutierrez C; Gaspar L; Muro R; Kreisler M; Ferriz P
    Lancet; 1983 Mar; 1(8325):644. PubMed ID: 6131317
    [No Abstract]   [Full Text] [Related]  

  • 10. Spanish toxic oil syndrome is a chemically induced GVHD-like epidemic.
    Kammüller ME; Penninks AH; Seinen W
    Lancet; 1984 May; 1(8387):1174-5. PubMed ID: 6144890
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidemic syndrome, Spain, 1981. Toxic Epidemic Syndrome Study Group.
    Lancet; 1982 Sep; 2(8300):697-702. PubMed ID: 6126635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the alimentary toxic oil syndrome due to ingestion of denatured rapeseed oil.
    Gilsanz V; Alvarez JL; Serrano S; Simón J
    Arch Intern Med; 1984 Feb; 144(2):254-6. PubMed ID: 6696559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic oil syndrome, Spain: effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats.
    Suarez A; Viloria MD; Garcia-Barreno P; Municio AM
    Arch Environ Contam Toxicol; 1985 Mar; 14(2):131-6. PubMed ID: 3920977
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
    Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
    Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
    Kammüller ME; Bloksma N; Seinen W
    J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells in the skin: progressive systemic sclerosis and the toxic oil syndrome.
    Fonseca E; Solís J
    Ann Intern Med; 1985 Jun; 102(6):864-5. PubMed ID: 3994202
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic oil syndrome: the perspective after 20 years.
    Posada de la Paz M; Philen RM; Borda AI
    Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic oil syndrome.
    Spurzem JR; Lockey JE
    Arch Intern Med; 1984 Feb; 144(2):249-50. PubMed ID: 6696556
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopathological aspects of the toxic oil syndrome catastrophe.
    López-Ibor JJ; Soria J; Cañas F; Rodriguez-Gamazo M
    Br J Psychiatry; 1985 Oct; 147():352-65. PubMed ID: 4075022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.